Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Jul 1.

Published in final edited form as: Am J Surg Pathol. 2021 Jul 1;45(7):951–961. doi: 10.1097/PAS.0000000000001685

Table 2:

Multivariable survival analysis: p16/HPV test combination groups.

Disease Free Survival	HRR^*	95% CI	Significance (P)
Double Positive (Reference category)	1.00
Discordant	1.91	0.93 – 3.95	0.08
Double Negative	3.64	2.40 – 5.53	*<0.001*
Age (HRR associated with an additional year of life)	1.03	1.01 – 1.05	*0.004*
Former or Current Smoker	2.28	1.40 – 3.73	*0.001*
T3/T4	1.56	1.05 – 2.33	*0.03*
Definitive / Chemo only	1.46	0.97 – 2.15	0.07

Overall Survival	HRR^*	95% CI	Significance (P)
Double Positive (Reference category)	1.00
Discordant	1.91	0.91 – 3.99	0.09
Double Negative	4.13	2.67 – 6.37	*<0.001*
Age (HRR associated with an additional year of life)	1.03	1.01 – 1.05	*0.01*
Former or Current Smoker	2.11	1.27 – 3.50	*0.004*
T3/T4	1.69	1.11 – 2.56	*0.01*
Definitive / Chemo Only	1.65	1.09 – 2.49	*0.02*
Double Positive (Reference category)	1.91	0.91 – 3.99	0.09

^*

Hazard Rate Ratio